Viewing Study NCT01262261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:04 PM
Ignite Modification Date: 2025-12-25 @ 5:05 PM
Study NCT ID: NCT01262261
Status: COMPLETED
Last Update Posted: 2018-12-31
First Post: 2010-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Re-Treatment Study of Probuphine in Opioid Addiction
Sponsor: Titan Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Opioid Dependency View
Keywords:

Keywords

Keyword Brief Keyword Text View
None opioid dependence View
None opioid addiction View
None buprenorphine View
None implant View
None methadone View
None heroin View
None suboxone View
None opioid pain medication View
None opioid withdrawal View